Amgen 2009 Annual Report Download - page 72

Download and view the complete annual report

Please find page 72 of the 2009 Amgen annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 180

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180

Performance graph
The chart set forth below shows the value of an investment of $100 on December 31, 2004 in each of Am-
gen Common Stock, the Amex Biotech Index, the Amex Pharmaceutical Index and Standard & Poor’s 500 Index
(the “S&P 500”). All values assume reinvestment of the pre-tax value of dividends paid by companies included
in these indices and are calculated as of December 31st of each year. The historical stock price performance of
the Company’s Common Stock shown in the performance graph below is not necessarily indicative of future
stock price performance.
Amgen vs. Amex Biotech, Amex Pharmaceutical and S&P 500 Indices
Comparison of Five Year Cumulative Total Return
Value of Investment of $100 on December 31, 2004
2004 2005 2006 2007 20092008
$0
$50
$100
$150
$200 Amgen (AMGN)
AMEX Biotech (BTK)
AMEX Pharmaceutical (DRG)
S&P 500 (SPX)
Dollar
Value
12/31/2004 12/31/2005 12/31/2006 12/31/2007 12/31/2008 12/31/2009
Amgen (AMGN) ................... $100.00 $122.93 $106.48 $ 72.39 $ 90.02 $ 88.18
Amex Biotech (BTK) ................ $100.00 $125.11 $138.59 $144.51 $118.91 $173.11
Amex Pharmaceutical (DRG) ......... $100.00 $103.54 $114.50 $115.66 $ 97.05 $113.53
S&P 500 (SPX) .................... $100.00 $104.83 $121.20 $127.85 $ 81.11 $102.15
The material in this performance graph is not soliciting material, is not deemed filed with the SEC, and is
not incorporated by reference in any filing of the Company under the Securities Act or the Exchange Act, wheth-
er made on, before or after the date of this filing and irrespective of any general incorporation language in such
filing.
60